Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Marx

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Ophthalmology (Auckland, N.Z.)|September 29, 2021
Utilization of Remote Diabetic Retinal Screening in a Suburban Healthcare SystemKristen H Kuo, Sidrah Anjum, Brian Nguyen, et al.
Retina (Philadelphia, Pa.)|June 4, 2009
Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicityCarolyn Anderson, Patricia Pahk, Gregory R Blaha, et al.
Retina (Philadelphia, Pa.)|July 11, 2007
Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study, David S Boyer, Paul M Beer, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 15, 2021
Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment CostsDavid J Ramsey, Samuel J Poulin, Lauren C LaMonica, et al.
American Journal of Ophthalmology|January 18, 2005
Symptoms of musculoskeletal disorders in ophthalmologistsKenneth C Dhimitri, Gerald McGwin, Sandre F McNeal, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 TrialsDarius M Moshfeghi, Seenu M Hariprasad, Jeffrey L Marx, et al.
American Journal of Ophthalmology|March 10, 2009
Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinoloneSteven J Yoon, David Y Rhee, Jeffrey L Marx, et al.
Ophthalmology|February 5, 2002
Homocysteine: a risk factor for retinal venous occlusive diseaseBruce A Brown, Jeffrey L Marx, Thomas P Ward, et al.
Retina (Philadelphia, Pa.)|August 28, 2014
Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medicationsGregory R Blaha, Nneka O Brooks, Charles E Mackel, et al.
Ocular Immunology and Inflammation|June 24, 2008
Intravascular lymphoma masquerading as Vogt-Koyanagi-Harada syndromePatricia J Pahk, Derrick J Todd, Gregory R Blaha, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Ophthalmology (Auckland, N.Z.)|September 29, 2021
Utilization of Remote Diabetic Retinal Screening in a Suburban Healthcare SystemKristen H Kuo, Sidrah Anjum, Brian Nguyen, et al.
Retina (Philadelphia, Pa.)|June 4, 2009
Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicityCarolyn Anderson, Patricia Pahk, Gregory R Blaha, et al.
Retina (Philadelphia, Pa.)|July 11, 2007
Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study, David S Boyer, Paul M Beer, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 15, 2021
Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment CostsDavid J Ramsey, Samuel J Poulin, Lauren C LaMonica, et al.
American Journal of Ophthalmology|January 18, 2005
Symptoms of musculoskeletal disorders in ophthalmologistsKenneth C Dhimitri, Gerald McGwin, Sandre F McNeal, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 TrialsDarius M Moshfeghi, Seenu M Hariprasad, Jeffrey L Marx, et al.
American Journal of Ophthalmology|March 10, 2009
Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinoloneSteven J Yoon, David Y Rhee, Jeffrey L Marx, et al.
Ophthalmology|February 5, 2002
Homocysteine: a risk factor for retinal venous occlusive diseaseBruce A Brown, Jeffrey L Marx, Thomas P Ward, et al.
Retina (Philadelphia, Pa.)|August 28, 2014
Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medicationsGregory R Blaha, Nneka O Brooks, Charles E Mackel, et al.
Ocular Immunology and Inflammation|June 24, 2008
Intravascular lymphoma masquerading as Vogt-Koyanagi-Harada syndromePatricia J Pahk, Derrick J Todd, Gregory R Blaha, et al.
Pageof 2